The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
HMN is in its pre commercial phase (ie not revenue generating). There is some cash for commercialisation of its research pipeline but there is still a lot of unproven risk. This is all priced into the current SP. There was a spike last year due to the Covid bounce everywhere in the pharma plays but this spike has long since deflated, and HMN is now trading in its pre Covid range of 1-2p once again. It will continue to do so until the pipelines commercialise.
https://www.ft.com/content/30415edc-1643-4334-a381-96ede6d88e2c
Yes, agreed, the patent approval is recent but wouldn't be of significant value. Bigger value is how Vlad manages the patent IP into revenue generation. In that context 1-2p is cheap and very much a punt. My point is the track record points the other direction. Time will tell.
GLAGI
That's all old news bladder, and by old I mean very old, and well before our 100% dilution. I don't care, you believe what you want, I just want to warn the unwary of the boiler room activities that have been rife on this share!
GLAGI
I see our Boiler Room friends are back! This has to be the rampiest, most uninformative and banal post in months. Could try harder. Beware of sucker investing, they are priming this one again folks.
GLAGI
A year ago this was trading at 1.2p-ish! Then we had a massive Covid bounce, helped by a good dose of ramping. GlobCo didn't way in with any deal and Mint diluted our share pool.
We have cash in the bank and a bit of time to see if Vlad has what it takes to convert pipedream to revenue generating pipelines. We'll know soon enough.
Meanwhile, assuming no significant news breaks, this share should hoover around the 1-2p range. Of course the ramping crew smell leverage and no doubt will continue their ramping campaign towards 3p.
GLAGI
If you trust the BOD that they now have enough cash to turn their innovations into revenue then this is probably the bottom. If you don't trust the BOD that they have enough cash then either hold out for another placing or forget about Hemp.
I feel those are our choices now.
BOD have shown significant incompetence to date so it is difficult to place any further trust....
GLAGI
Not that anyone actually goes fishing for bin lids but that is what this share feels like at the mo.
I had said previously that I sold 2/3rds here back at 4.4p and I thought then this was heading back to a preCovid SP price range of 1-2p. But the drag to get down to that level has been painfully slow.
Once we are there though something has to give, either way. Will Mint be feeling squeezed at that level? Will Hemp have enough cash to bring any of its pipeline out of pipedream territory?
Obviously time will tell.
We are nearly at the bottom of this cycle IMO and we need positive news to lift us from this bottom.
One piece of positive is those nasty boiler room people are not so in your face now. For now.....
GLAGI
Some have mentioned an oversold play here. You are now close to this stock and will have a sense for it. If you can catch the bottom of the oversell and have the nerve to jump back in, then you might recoup some of your losses. Takes a lot of nerve though and finding a bottom is never easy!
This SP seems to be heading back now to pre Covid levels, ie 1-2p. Will that simply be a normalizing event?
I'm not sure. In that sense this is now more a dampening or smoothing of the trends.
The unknown, of course, is what are the effects of everything that has happened since pre Covid?
I feel we have to get back to 1-2p first before we can get a feeling for that.
GLAGI